Literature DB >> 7504783

GABAA receptor needs two homologous domains of the beta-subunit for activation by GABA but not by pentobarbital.

J Amin1, D S Weiss.   

Abstract

The predominant inhibitory neurotransmitter of the brain, GABA (gamma-aminobutyric acid), activates chloride-selective ion pores integral to the receptor complex. Subunits comprising the presumed hetero-pentameric GABA channel have been cloned, but little information is available on the domains important for activation. Rat wild-type or mutated alpha 1-, beta 2- and gamma 2-subunits (designated alpha, beta and gamma) were coexpressed in Xenopus oocytes and examined electrophysiologically. We report here the identification of two separate and homologous domains of the beta-subunit, each of which contributes a tyrosine and threonine essential for activation by GABA. Conservative substitution of each of these four amino acids dramatically decreased GABA channel sensitivity to activation by GABA and the GABA agonist muscimol. These substitutions, however, did not impair activation by the barbiturate pentobarbital, indicating these two different classes of agonists activate GABA channels through distinct mechanisms. We also present evidence suggesting that the two identified domains of the beta-subunit contribute a major component of the GABA receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7504783     DOI: 10.1038/366565a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  138 in total

Review 1.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

2.  Structural domains of the human GABAA receptor 3 subunit involved in the actions of pentobarbital.

Authors:  R Serafini; J Bracamontes; J H Steinbach
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

3.  Allosteric modulators affect the efficacy of partial agonists for recombinant GABA(A) receptors.

Authors:  G Maksay; S A Thompson; K A Wafford
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

4.  Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine.

Authors:  Y Chang; D S Weiss
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

5.  Positive allosteric modulation by ultraviolet irradiation on GABA(A), but not GABA(C), receptors expressed in Xenopus oocytes.

Authors:  Y Chang; Y Xie; D S Weiss
Journal:  J Physiol       Date:  2001-10-15       Impact factor: 5.182

6.  Microscopic kinetics and energetics distinguish GABA(A) receptor agonists from antagonists.

Authors:  M V Jones; P Jonas; Y Sahara; G L Westbrook
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

7.  Prediction of 5-HT3 receptor agonist-binding residues using homology modeling.

Authors:  David C Reeves; Muhammed F R Sayed; Pak-Lee Chau; Kerry L Price; Sarah C R Lummis
Journal:  Biophys J       Date:  2003-04       Impact factor: 4.033

8.  Desensitization mechanism of GABA receptors revealed by single oocyte binding and receptor function.

Authors:  Yongchang Chang; Emmanuel Ghansah; Yonghui Chen; Jiawei Ye; David S Weiss; YongChang Chang
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  An arginine involved in GABA binding and unbinding but not gating of the GABA(A) receptor.

Authors:  David A Wagner; Cynthia Czajkowski; Mathew V Jones
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

10.  Pentameric ligand-gated ion channel ELIC is activated by GABA and modulated by benzodiazepines.

Authors:  Radovan Spurny; Joachim Ramerstorfer; Kerry Price; Marijke Brams; Margot Ernst; Hugues Nury; Mark Verheij; Pierre Legrand; Daniel Bertrand; Sonia Bertrand; Dennis A Dougherty; Iwan J P de Esch; Pierre-Jean Corringer; Werner Sieghart; Sarah C R Lummis; Chris Ulens
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.